Area of research
Biochemistry · Hematology
Research interest
Research interests include Blood transfusion and management, Blood donation and transfusion practices, Platelet Disorders and Treatments, and Blood groups and transfusion.
Investigation on the Influence of Protein Corona and Platelet Adhesion on Storage Bag Surface on the Platelet Storage Lesion.
Manufacturing stresses do not differentially impact red blood cells from donors with diabetes.
Genetic engineering of transfusable platelets with mRNA-lipid nanoparticles is compatible with blood banking practices.
Characterization and Hemocompatibility of α, β, and γ Cyclodextrin-Modified Magnetic Nano-Adsorbents.
Assessment of the soluble proteins HMGB1, CD40L and CD62P during various platelet preparation processes and the storage of platelet concentrates: The BEST collaborative study.
Hemocompatibility of β-Cyclodextrin-Modified (Methacryloyloxy)ethyl Phosphorylcholine Coated Magnetic Nanoparticles.
Navigating imperfect policies to donate plasma: Survey on plasma donation and a pilot plasma donation program among men who have sex with men in Canada.
What influences decisions to donate plasma? A rapid review of the literature.
Clinical Practice Guidelines From the Association for the Advancement of Blood and Biotherapies (AABB): COVID-19 Convalescent Plasma
Clinical Practice Guidelines From the Association for the Advancement of Blood and Biotherapies (AABB): COVID-19 Convalescent Plasma.
The Missing Pieces to the Cold-Stored Platelet Puzzle.
Retention of hemostatic and immunological properties of frozen plasma and COVID-19 convalescent apheresis fresh-frozen plasma produced and freeze-dried in Canada.
Staff perspectives on barriers and enablers to implementing alternative source plasma eligibility criteria for gay, bisexual, and other men who have sex with men.
Minimal impact of anticoagulant on in vitro whole blood quality throughout a 35-day cold-storage regardless of leukoreduction timing.
U.S. cities will not meet blood product resuscitation standards during major mass casualty incidents: Results of a THOR-AABB working party prospective analysis.
Early and out-of-hospital use of COVID-19 convalescent plasma: An international assessment of utilization and feasibility.
Cold-stored platelets are effective in an in vitro model of massive transfusion protocol assessed by rotational thromboelastometry.
Rejuvenated and safe: Freeze-dried plasma for the 21st century.
Freeze-dried plasma: From damage control resuscitation to coronavirus disease 2019 therapy.
Impact of product platelet count reduction on platelet demand in Canada.
Effect of modern infusion pumps on RBC quality.
A data-informed system to manage scarce blood product allocation in a randomized controlled trial of convalescent plasma.
National Blood Foundation 2021 Research and Development summit: Discovery, innovation, and challenges in advancing blood and biotherapies.
Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial
ABO blood group and COVID‐19: a review on behalf of the ISBT COVID‐19 Working Group
<scp>COVID</scp>‐19 convalescent plasma: Interim recommendations from the <scp>AABB</scp>
Guidance for the procurement of COVID-19 convalescent plasma: differences between high- and low-middle-income countries.
COVID-19 convalescent plasma: Interim recommendations from the AABB.
<i>In Vitro</i> Characterization and Metabolomic Analysis of Cold-Stored Platelets.
Clinical use of Convalescent Plasma in the COVID-19 pandemic: a transfusion-focussed gap analysis with recommendations for future research priorities.